Olaf Sowade

1.1k total citations
8 papers, 184 citations indexed

About

Olaf Sowade is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Olaf Sowade has authored 8 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Ophthalmology, 6 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Olaf Sowade's work include Retinal Imaging and Analysis (6 papers), Retinal Diseases and Treatments (6 papers) and Retinal and Optic Conditions (5 papers). Olaf Sowade is often cited by papers focused on Retinal Imaging and Analysis (6 papers), Retinal Diseases and Treatments (6 papers) and Retinal and Optic Conditions (5 papers). Olaf Sowade collaborates with scholars based in Germany, United States and Japan. Olaf Sowade's co-authors include Harald Siedentop, Karl Wegscheider, Uwe Kuehl, Felicitas Escher, Finn Waagstein, Eloisa Arbustini, Matthias Pauschinger, Cornelia Piper, Heinz‐Peter Schultheiß and Yuichiro Ogura and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, British Journal of Ophthalmology and Retina.

In The Last Decade

Olaf Sowade

8 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf Sowade Germany 6 88 79 77 26 24 8 184
Rishi Suresh United States 6 29 0.3× 12 0.2× 28 0.4× 11 0.4× 43 1.8× 15 121
Tali Eviatar Israel 7 18 0.2× 8 0.1× 20 0.3× 29 1.1× 15 0.6× 21 130
Naghmeh Ziaei Iran 5 49 0.6× 13 0.2× 4 0.1× 10 0.4× 10 0.4× 9 121
David M. Weinreich United States 6 88 1.0× 4 0.1× 66 0.9× 13 0.5× 22 0.9× 9 244
Ekaterina V. Denisova Russia 4 62 0.7× 14 0.2× 9 0.1× 11 0.4× 30 88
George E. McLaughlin United States 7 29 0.3× 16 0.2× 4 0.1× 5 0.2× 22 0.9× 10 127
Mihai Mititelu United States 9 216 2.5× 2 0.0× 66 0.9× 17 0.7× 10 0.4× 19 252
Milad Gholizadeh Mesgarha Iran 7 5 0.1× 11 0.1× 11 0.1× 15 0.6× 42 1.8× 19 127
Robert S. Wirthlin United States 6 54 0.6× 6 0.1× 25 0.3× 22 0.8× 2 0.1× 10 96
Shady Suffo Germany 11 226 2.6× 7 0.1× 233 3.0× 18 0.7× 7 0.3× 39 283

Countries citing papers authored by Olaf Sowade

Since Specialization
Citations

This map shows the geographic impact of Olaf Sowade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Sowade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Sowade more than expected).

Fields of papers citing papers by Olaf Sowade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Sowade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Sowade. The network helps show where Olaf Sowade may publish in the future.

Co-authorship network of co-authors of Olaf Sowade

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Sowade. A scholar is included among the top collaborators of Olaf Sowade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Sowade. Olaf Sowade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Terasaki, Hiroko, Kunihiko Shiraki, Masahito Ohji, et al.. (2018). EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN. Retina. 39(5). 938–947. 6 indexed citations
2.
Lanzetta, Paolo, Alan F. Cruess, Salomon Y. Cohen, et al.. (2018). Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: post hoc analysis of the VIEW studies. Acta Ophthalmologica. 96(8). e911–e918. 20 indexed citations
3.
Li, Xiaoxin, Youxin Chen, Junjun Zhang, et al.. (2017). Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study. Journal of Ocular Pharmacology and Therapeutics. 33(6). 435–444. 4 indexed citations
4.
Brazier, John, Dominic Muston, G. Sarah Power, et al.. (2017). Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies. Investigative Ophthalmology & Visual Science. 58(11). 4818–4818. 15 indexed citations
5.
Wong, Tien Yin, Chui Ming Gemmy Cheung, Timothy Y. Y. Lai, et al.. (2017). EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 39(3). 537–547. 10 indexed citations
6.
Schultheiß, Heinz‐Peter, Cornelia Piper, Olaf Sowade, et al.. (2016). Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-β treatment in patients with chronic viral cardiomyopathy. Clinical Research in Cardiology. 105(9). 763–773. 89 indexed citations
7.
Ogura, Yuichiro, Hiroko Terasaki, Fumi Gomi, et al.. (2014). Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study. British Journal of Ophthalmology. 99(1). 92–97. 39 indexed citations
8.
Sowade, Olaf, Werner W. Franke, Peter Stephan, et al.. (1997). Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients. American Journal of Hematology. 55(2). 89–96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026